Perplexity AI Forecasts Moderna Stock Performance Through 2026

Perplexity AI predicts Moderna's stock could reach between $180 and $240 by the end of 2026, with a bullish base case of $210. The primary catalyst for this growth is the personalized mRNA cancer vaccine, Intismeran.